Vienna, Austria’s capital, lies in the country’s east on the Danube River. Its artistic and intellectual legacy was shaped by residents including Mozart, Beethoven and Sigmund Freud. The city is also known for its Imperial palaces, including Schönbrunn, the Habsburgs’ summer residence. In the MuseumsQuartier district, historic and contemporary buildings display works by Egon Schiele, Gustav Klimt and other artists. ― Google

During the past decade, University of Vienna conducted 18 clinical trials. In the 10-year time frame, 18 clinical trials started and 2 clinical trials were completed, i.e. on average, 11.1% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 2 clinical trials were completed. i.e. 15.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Vienna" #1 sponsor was "University of Vienna" with 12 trials, followed by "IFAG AG" with 2 trials sponsored, "United Therapeutics" with 2 trials sponsored, "Allergan" with 1 trials sponsored and "Archemix Corp." with 1 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Vienna" #1 collaborator was "Medical University of Vienna" with 4 trials as a collaborator, "University of Vienna" with 3 trials as a collaborator, "Hiscia Society for Cancer Research" with 2 trials as a collaborator, "Assistance Publique - Hôpitaux de Paris" with 1 trials as a collaborator and "Bart's London" with 1 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 21 trials.

According to Clinical.Site data, the most researched conditions in "University of Vienna" are "Colorectal Cancer" (2 trials), "Endotoxemia" (2 trials), "Inflammatory Response" (2 trials), "Pulmonary Hypertension" (2 trials) and "Stress" (2 trials). Many other conditions were trialed in "University of Vienna" in a lesser frequency.

Most popular intervention types in "University of Vienna" are "Other" (11 trials), "Drug" (10 trials), "Behavioral" (5 trials), "Dietary Supplement" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), ""Amateur" Group Singing" (1 trials), ""Professional" Group Singing" (1 trials), "68Ga-NODAGA-exendin-4 PET/CT" (1 trials) and "ARC 1779 Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Vienna" are 23 trials for "All" genders, 5 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University of Vienna". undefined are not yet recruiting, 7 are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 13 completed trials in University of Vienna, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University of Vienna, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 13 trials that are defined as “Not Applicable".